Skip to main content
NCBI home page
Applied Microbiology logoLink to Applied Microbiology
. 1971 Sep;22(3):255–259. doi: 10.1128/am.22.3.255-259.1971

Large-Scale Purification of Rubella Virus and Preparation of an Experimental Split Rubella Virus Vaccine

Pertti Väänänen 1,2, Antti Vaheri 1,2
PMCID: PMC376293  PMID: 5119198

Abstract

Large-scale purification of rubella virus from tissue culture fluid and preparation of an experimental rubella subunit vaccine are described. The virus, purified isopycnically in sucrose gradients, was Tween 80-ether treated, and the product was filtered sterile. The vaccines were of two types, formalinized and nonformalinized. They were not infectious, had only a slight pyrogenicity, and caused no harmful symptoms in animals. The immune response in guinea pigs was better when the nonformalinized vaccine was used and the dosage was 2,500 hemagglutinating units per injection (0.5 ml).

Full text

PDF
255

Images in this article

257Image
on p.257
257Image
on p.257

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON N. G. VIRUS ISOLATION IN THE ZONAL ULTRACENTRIFUGE. Nature. 1963 Sep 21;199:1166–1168. doi: 10.1038/1991166a0. [DOI] [PubMed] [Google Scholar]
  2. Anderson N. G., Barringer H. P., Amburgey J. W., Jr, Cline G. B., Nunley C. E., Berman A. S. Continuous-flow centrifugation combined with isopycnic banding: rotors B-8 and B-IX. Natl Cancer Inst Monogr. 1966 Jun;21:199–216. [PubMed] [Google Scholar]
  3. Beck E. S. Review of studies with inactivated rubella virus. Am J Dis Child. 1969 Aug;118(2):328–333. doi: 10.1001/archpedi.1969.02100040330030. [DOI] [PubMed] [Google Scholar]
  4. Cline G. B., Nunley C. E., Anderson N. G. Improved continuous flow centrifugation with banding. Nature. 1966 Oct 29;212(5061):487–489. doi: 10.1038/212487a0. [DOI] [PubMed] [Google Scholar]
  5. FRANKEL J. W. NEUTRALIZING ANTIBODY RESPONSES OF GUINEA-PIGS TO INACTIVATED RUBELLA VIRUS VACCINE. Nature. 1964 Nov 14;204:655–656. doi: 10.1038/204655a0. [DOI] [PubMed] [Google Scholar]
  6. Fulginiti V. A., Arthur J. H., Pearlman D. S., Kempe C. H. Altered reactivity to measles virus: local reactions following attenuated measles virus immunization in children who previously received a combination of inactivated and attenuated vaccines. Am J Dis Child. 1968 Jun;115(6):671–676. doi: 10.1001/archpedi.1968.02100010673006. [DOI] [PubMed] [Google Scholar]
  7. Furukawa T., Plotkin S., Sedwick D., Profeta M. Haemagglutinin of rubella virus. Nature. 1967 Jul 8;215(5097):172–173. doi: 10.1038/215172a0. [DOI] [PubMed] [Google Scholar]
  8. Gardner P. S., McQuillin J., Court S. D. Speculation on pathogenesis in death from respiratory syncytial virus infection. Br Med J. 1970 Feb 7;1(5692):327–330. doi: 10.1136/bmj.1.5692.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gokiert J. G., Beamish W. E. Altered reactivity to measles virus in previously vaccinated children. Can Med Assoc J. 1970 Oct 10;103(7):724–727. [PMC free article] [PubMed] [Google Scholar]
  10. Halonen P. E., Stewart J. A., Hall A. D. Rubella hemagglutinin prepared in serum free suspension culture of BHK-21 cells. Ann Med Exp Biol Fenn. 1967;45(2):182–185. [PubMed] [Google Scholar]
  11. Hilleman M. R., Buynak E. B., Whitman J. E., Jr, Weibel R. W., Stokes J., Jr Live attenuated rubella virus vaccines. Experiences with duck embryo cell preparations. Am J Dis Child. 1969 Aug;118(2):166–171. doi: 10.1001/archpedi.1969.02100040168002. [DOI] [PubMed] [Google Scholar]
  12. Horstmann D. M., Liebhaber H., Kohorn E. I. Post-partum vaccination of rubella-susceptible women. Lancet. 1970 Nov 14;2(7681):1003–1006. doi: 10.1016/s0140-6736(70)92814-x. [DOI] [PubMed] [Google Scholar]
  13. Horstmann D. M., Liebhaber H., Le Bouvier G. L., Rosenberg D. A., Halstead S. B. Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic. N Engl J Med. 1970 Oct 8;283(15):771–778. doi: 10.1056/NEJM197010082831501. [DOI] [PubMed] [Google Scholar]
  14. Hovi T., Vaheri A. Infectivity and some physicochemical characteristics of rubella virus ribonucleic acid. Virology. 1970 Sep;42(1):1–8. doi: 10.1016/0042-6822(70)90232-1. [DOI] [PubMed] [Google Scholar]
  15. Laufs R., Thomssen R. Eigenschaften eines mit Tween 80 und Athyläther behandelten Rubellavirus-Hämmagglutinins. Arch Gesamte Virusforsch. 1968;24(3):164–180. [PubMed] [Google Scholar]
  16. McCombs R. M., Rawls W. E. Density gradient centrifugation of rubella virus. J Virol. 1968 May;2(5):409–414. doi: 10.1128/jvi.2.5.409-414.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Meyer H. M., Jr, Parkman P. D., Hobbins T. E., Ennis F. A. Clinical studies with experimental live rubella virus vaccine (strain HPV-77). Evaluation of vaccine-induced immunity. Am J Dis Child. 1968 Jun;115(6):648–654. doi: 10.1001/archpedi.1968.02100010650002. [DOI] [PubMed] [Google Scholar]
  18. NORRBY E. Hemagglutination by measles virus. III. Identification of two different hemagglutinins. Virology. 1963 Feb;19:147–157. doi: 10.1016/0042-6822(63)90004-7. [DOI] [PubMed] [Google Scholar]
  19. NORRBY E., LAGERCRANTZ R., GARD S. MEASLES VACCINATION. IV. RESPONSES TO TWO DIFFERENT TYPES OF PREPARATIONS GIVEN AS A FOURTH DOSE OF VACCINE. Br Med J. 1965 Mar 27;1(5438):813–817. [PMC free article] [PubMed] [Google Scholar]
  20. Phillips C. A., Maeck J. V., Rogers W. A., Savel H. Intrauterine rubella infection following immunization with rubella vaccine. JAMA. 1970 Jul 27;213(4):624–625. [PubMed] [Google Scholar]
  21. STOKER M., MACPHERSON I. SYRIAN HAMSTER FIBROBLAST CELL LINE BHK21 AND ITS DERIVATIVES. Nature. 1964 Sep 26;203:1355–1357. doi: 10.1038/2031355a0. [DOI] [PubMed] [Google Scholar]
  22. Schiff G. M., Donath R., Rotte T. Experimental rubella studies. I. Clinical and laboratory features of infection caused by the Brown strain rubella virus. II. Artificial challenge studies of adult rubella vaccinees. Am J Dis Child. 1969 Aug;118(2):269–274. doi: 10.1001/archpedi.1969.02100040271024. [DOI] [PubMed] [Google Scholar]
  23. Vaheri A., Penttinen K., Vänänen P., von Bonsdorff C. H. Hemagglutination activity and morphology of influenza virus. Arch Environ Health. 1970 Sep;21(3):328–331. doi: 10.1080/00039896.1970.10667247. [DOI] [PubMed] [Google Scholar]
  24. Vaheri A., Vesikari T., Oker-Blom N., Seppala M., Veronelli J., Robbins F. C., Parkman P. D. Transmission of attenuated rubella vaccines to the human fetus. A preliminary report. Am J Dis Child. 1969 Aug;118(2):243–246. doi: 10.1001/archpedi.1969.02100040245016. [DOI] [PubMed] [Google Scholar]
  25. Vaheri A., von Bonsdorff C. H., Vesikari T., Hovi T., Vänänen P. Purification of rubella virus particles. J Gen Virol. 1969 Jul;5(1):39–46. doi: 10.1099/0022-1317-5-1-39. [DOI] [PubMed] [Google Scholar]
  26. Wilkins J., Leedom J. M., Portnoy B., Salvatore M. A. Reinfection with rubella virus despite live vaccine induced immunity. Trials of HPV-77 and HPV-80 live rubella virus vaccines and subsequent artificial and natural challenge studies. Am J Dis Child. 1969 Aug;118(2):275–294. doi: 10.1001/archpedi.1969.02100040277025. [DOI] [PubMed] [Google Scholar]

Articles from Applied Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES